Gilead Sciences announced plans to invest €7 million in the company's Irish operations on Wednesday.

Gilead announce Cork expansion

The majority of 140 jobs that were announced by Gilead this week will be Dublin-based “with a small few” going to Cork, the Cork Independent has learned.

Gilead Sciences, a biopharmaceutical company, announced plans to invest €7 million in the company’s Irish operations, opening a new base in Dublin and creating 140 jobs. As part of this expansion, the company will also establish a paediatric centre of excellence in Ireland.

Gilead announced the news yesterday (Wednesday) morning. However, there was some confusion about where the majority of jobs would be based.

A spokesperson for Gilead confirmed to the Cork Independent: “The vast majority of the jobs will be located at Gilead’s new Dublin office, with a small few going into the existing Cork operation.”

The company confirmed that it has started the recruitment process and expects the positions to be filled by early 2022.

Gilead is adding positions at all levels in departments including clinical development, process development and analytical operations, legal, human resources, supply chain, information technology, facilities and engineering, and financial shared services.

Gilead’s sites in Ireland include a drug product manufacturing and packing facility in Carrigtwohill that manufactures and packages 22 Gilead drug products. The facility manufactures HIV and HCV solid oral products, representing 25 per cent of Gilead’s total solid oral drug production.

The company also has a financial shared services centre in Little Island which supports Gilead affiliates in Europe, Middle East, Asia and South America and was established 11 years ago, and a distribution centre in Dublin that distributes to 90 markets worldwide.